TELA BIO INC. - COMMO

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09 5 2025 16:05:00 提供 Nasdaq GlobeNewswire

TELA Bio Reports First Quarter 2025 Financial Results

08 5 2025 16:03:29 提供 Nasdaq GlobeNewswire

TELA Bio to Announce First Quarter 2025 Financial Results

17 4 2025 16:05:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery

31 3 2025 07:00:00 提供 Nasdaq GlobeNewswire

TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results

20 3 2025 16:05:00 提供 Nasdaq GlobeNewswire

TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results

27 2 2025 16:05:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

21 2 2025 16:05:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

24 1 2025 16:05:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 12 2024 16:05:00 提供 Nasdaq GlobeNewswire

TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference

19 11 2024 16:05:00 提供 Nasdaq GlobeNewswire

TELA Bio Reports Third Quarter 2024 Financial Results

07 11 2024 16:05:01 提供 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 11 2024 16:05:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

24 10 2024 16:05:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

23 10 2024 08:07:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

22 10 2024 16:05:44 提供 Nasdaq GlobeNewswire

TELA Bio to Announce Third Quarter 2024 Financial Results

17 10 2024 16:05:00 提供 Nasdaq GlobeNewswire

TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance

12 8 2024 16:05:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09 8 2024 16:05:00 提供 Nasdaq GlobeNewswire

TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference

25 7 2024 16:05:00 提供 Nasdaq GlobeNewswire

TELA Bio to Announce Second Quarter 2024 Financial Results

22 7 2024 16:05:00 提供 Nasdaq GlobeNewswire